{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:25:28Z","timestamp":1790925928657,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council UK","doi-asserted-by":"crossref","award":["UK DRI Programme"],"award-info":[{"award-number":["UK DRI Programme"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recent studies have identified roles for complement in synaptic pruning, both physiological during development and pathological in Alzheimer\u2019s disease (AD). These reports suggest that C1q initiates complement activation on synapses and C3 fragments then tag them for removal by microglia. There is an urgent need to characterise these processes in rodent AD models; this requires the development of reagents and methods for detection and quantification of rodent C1q in fluids and pathological tissues. These will enable better evaluation of the role of C1q in disease and its value as disease biomarker. We describe the generation in C1q-deficient mice of novel monoclonal antibodies against mouse and rat C1q that enabled development of a sensitive, specific, and quantitative ELISA for mouse and rat C1q capable of measuring C1q in biological fluids and tissue extracts. Serum C1q levels were measured in wild-type (WT),\n                    <jats:italic>C1q<\/jats:italic>\n                    knockout (KO),\n                    <jats:italic>C3<\/jats:italic>\n                    KO,\n                    <jats:italic>C7<\/jats:italic>\n                    KO,\n                    <jats:italic>Crry<\/jats:italic>\n                    KO, and 3xTg and APP\n                    <jats:sup>NL-G-F<\/jats:sup>\n                    AD model mice through ageing. C1q levels significantly decreased in WT, APP\n                    <jats:sup>NL-G-F<\/jats:sup>\n                    , and C7 KO mice with ageing. C1q levels were reduced in APP\n                    <jats:sup>NL-G-F<\/jats:sup>\n                    compared to WT at all ages and in 3xTg at 12\u00a0months;\n                    <jats:italic>C3<\/jats:italic>\n                    KO and\n                    <jats:italic>C7<\/jats:italic>\n                    KO, but not\n                    <jats:italic>Crry<\/jats:italic>\n                    KO mice, also demonstrated significantly lower C1q levels compared to matched WT. In brain homogenates, C1q levels increased with age in both WT and APP\n                    <jats:sup>NL-G-F<\/jats:sup>\n                    mice. This robust and adaptable assay for quantification of mouse and rat C1q provides a vital tool for investigating the expression of C1q in rodent models of AD and other complement-driven pathologies.\n                  <\/jats:p>","DOI":"10.1007\/s12035-021-02419-5","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:02:37Z","timestamp":1621281757000},"page":"4323-4336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Novel Monoclonal Antibodies Against Mouse C1q: Characterisation and Development of a Quantitative ELISA for Mouse C1q"],"prefix":"10.1007","volume":"58","author":[{"given":"Robert A. J.","family":"Byrne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Torvell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoleta","family":"Daskoulidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Fathalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Kokkali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Carpanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-7676","authenticated-orcid":false,"given":"B. Paul","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"issue":"10","key":"2419_CR1","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nature Genet 41(10):1088\u20131093. https:\/\/doi.org\/10.1038\/ng.440","journal-title":"Nature Genet"},{"issue":"10","key":"2419_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nature Genet 41(10):1094\u20131099. https:\/\/doi.org\/10.1038\/ng.439","journal-title":"Nature Genet"},{"issue":"12","key":"2419_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nature Genet 45(12):1452\u20131458. https:\/\/doi.org\/10.1038\/ng.2802","journal-title":"Nature Genet"},{"issue":"3","key":"2419_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M et al (2019) Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nature Genet 51(3):414\u2013430. https:\/\/doi.org\/10.1038\/s41588-019-0358-2","journal-title":"Nature Genet"},{"issue":"2","key":"2419_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-160420","volume":"54","author":"S Hakobyan","year":"2016","unstructured":"Hakobyan S, Harding K, Aiyaz M, Hye A, Dobson R, Baird A, Liu B, Harris CL et al (2016) Complement biomarkers as predictors of disease progression in Alzheimer\u2019s disease. J Alz Dis 54(2):707\u2013716. https:\/\/doi.org\/10.3233\/JAD-160420","journal-title":"J Alz Dis"},{"key":"2419_CR6","doi-asserted-by":"publisher","unstructured":"Hu WT, Watts KD, Tailor P, Nguyen TP, Howell JC, Lee RC, Seyfried NT, Gearing M et al (2016) CSF complement 3 and factor H are staging biomarkers in Alzheimer\u2019s disease. Acta Neuropathol Comm 4(14). https:\/\/doi.org\/10.1186\/s40478-016-0277-8","DOI":"10.1186\/s40478-016-0277-8"},{"issue":"1","key":"2419_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-160889","volume":"56","author":"AR Morgan","year":"2017","unstructured":"Morgan AR, Touchard S, O\u2019Hagan C, Sims R, Majounie E, Escott-Price V, Jones L, Williams J et al (2017) The correlation between inflammatory biomarkers and polygenic risk score in Alzheimer\u2019s disease. J Alz Dis 56(1):25\u201336. https:\/\/doi.org\/10.3233\/JAD-160889","journal-title":"J Alz Dis"},{"issue":"6","key":"2419_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","volume":"15","author":"AR Morgan","year":"2019","unstructured":"Morgan AR, Touchard S, Leckey C, O\u2019Hagan C, Nevado-Holgado AJ, NIMA Consortium, Barkhof F, Bertram L, Blin O et al (2019) Inflammatory biomarkers in Alzheimer\u2019s disease plasma. Alz Dement 15(6):776\u2013787. https:\/\/doi.org\/10.1016\/j.jalz.2019.03.007","journal-title":"Alz Dement"},{"issue":"12","key":"2419_CR9","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.jalz.2018.07.223","volume":"14","author":"KL Rasmussen","year":"2018","unstructured":"Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF (2018) An updated Alzheimer hypothesis: complement C3 and risk of Alzheimer\u2019s disease\u2014A cohort study of 95,442 individuals. Alz Dement 14(12):1589\u20131601. https:\/\/doi.org\/10.1016\/j.jalz.2018.07.223","journal-title":"Alz Dement"},{"issue":"179","key":"2419_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-9-179","volume":"9","author":"DH Cribbs","year":"2012","unstructured":"Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ, Cotman CW (2012) Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflamm 9(179):1\u201318. https:\/\/doi.org\/10.1186\/1742-2094-9-179","journal-title":"J Neuroinflamm"},{"issue":"4","key":"2419_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/BF00687336","volume":"63","author":"T Ishii","year":"1984","unstructured":"Ishii T, Haga S (1984) Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol 63(4):296\u2013300. https:\/\/doi.org\/10.1007\/BF00687336","journal-title":"Acta Neuropathol"},{"issue":"21","key":"2419_CR12","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","volume":"89","author":"J Rogers","year":"1992","unstructured":"Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L et al (1992) Complement activation by \u03b2-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 89(21):10016\u201310020. https:\/\/doi.org\/10.1073\/pnas.89.21.10016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2419_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00401-002-0624-7","volume":"105","author":"R Veerhuis","year":"2003","unstructured":"Veerhuis R, Van Breemen MJ, Hoozemans JM, Morbin M, Ouladhadj J, Tagliavini F, Eikelenboom P et al (2003) Amyloid \u03b2 plaque-associated proteins C1q and SAP enhance the A\u03b21-42 peptide-induced cytokine secretion by adult human microglia in vitro. Acta Neuropathol 105(2):135\u2013144. https:\/\/doi.org\/10.1007\/s00401-002-0624-7","journal-title":"Acta Neuropathol"},{"issue":"16","key":"2419_CR14","doi-asserted-by":"publisher","first-page":"10837","DOI":"10.1073\/pnas.162350199","volume":"99","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Yan F, Lin AH, Lambris JD, Alexander JJ, Quigg RJ, Masliah E (2002) Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer\u2019s mice. Proc Natl Acad Sci U S A 99(16):10837\u201310842. https:\/\/doi.org\/10.1073\/pnas.162350199","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"2419_CR15","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","volume":"28","author":"M Maier","year":"2008","unstructured":"Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, Lemere CA (2008) Complement C3 deficiency leads to accelerated amyloid \u03b2 plaque deposition and neurodegeneration and modulation of the microglia\/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci 28(25):6333\u20136341. https:\/\/doi.org\/10.1523\/JNEUROSCI.0829-08.2008","journal-title":"J Neurosci"},{"key":"2419_CR16","doi-asserted-by":"publisher","unstructured":"Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, Stevens B, Lemere CA (2017) Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Science Trans Med 9(392). https:\/\/doi.org\/10.1126\/scitranslmed.aaf6295","DOI":"10.1126\/scitranslmed.aaf6295"},{"issue":"1","key":"2419_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/bj1550019","volume":"155","author":"KBM Reid","year":"1976","unstructured":"Reid KBM, Porter RR (1976) Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem J 155(1):19\u201323. https:\/\/doi.org\/10.1042\/bj1550019","journal-title":"Biochem J"},{"issue":"2","key":"2419_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1084\/jem.125.2.359","volume":"125","author":"HJ M\u00fcller-Eberhard","year":"1967","unstructured":"M\u00fcller-Eberhard HJ, Polley MJ, Calcott MA (1967) Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. J Exp Med 125(2):359\u2013380","journal-title":"J Exp Med"},{"issue":"1","key":"2419_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1084\/jem.132.4.775","volume":"123","author":"HJ M\u00fcller-Eberhard","year":"1966","unstructured":"M\u00fcller-Eberhard HJ, Dalmasso A, Calcott M (1966) The reaction mechanism of beta-1C-globulin (C\u20193) in immune hemolysis. J Exp Med 123(1):33\u201354. https:\/\/doi.org\/10.1084\/jem.132.4.775","journal-title":"J Exp Med"},{"key":"2419_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1084\/jem.127.2.371","volume":"127","author":"C Cochrane","year":"1968","unstructured":"Cochrane C, M\u00fcller-Eberhard H (1968) The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med 127:371\u2013386","journal-title":"J Exp Med"},{"key":"2419_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10587","volume":"7","author":"M Serna","year":"2016","unstructured":"Serna M, Giles JL, Morgan BP, Bubeck D (2016) Structural basis of complement membrane attack complex formation. Nature Comm 7:1\u20137. https:\/\/doi.org\/10.1038\/ncomms10587","journal-title":"Nature Comm"},{"issue":"6","key":"2419_CR22","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK et al (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131(6):1164\u20131178. https:\/\/doi.org\/10.1016\/j.cell.2007.10.036","journal-title":"Cell"},{"issue":"12","key":"2419_CR23","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/nn.3560","volume":"16","author":"AR Bialas","year":"2013","unstructured":"Bialas AR, Stevens B (2013) TGF-\u03b2 signaling regulates neuronal C1q expression and developmental synaptic refinement. Nature Neurosci 16(12):1773\u20131782. https:\/\/doi.org\/10.1038\/nn.3560","journal-title":"Nature Neurosci"},{"issue":"7589","key":"2419_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J et al (2016) Schizophrenia risk from complex variation of complement component 4. Nature 530(7589):177\u2013183. https:\/\/doi.org\/10.1038\/nature16549","journal-title":"Nature"},{"issue":"6048","key":"2419_CR25","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA et al (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333(6048):1456\u20131458. https:\/\/doi.org\/10.1126\/science.1202529","journal-title":"Science"},{"issue":"4","key":"2419_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME et al (2012) Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74(4):691\u2013705. https:\/\/doi.org\/10.1016\/j.neuron.2012.03.026","journal-title":"Neuron"},{"issue":"10","key":"2419_CR27","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging 27(10):1372\u20131384. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.09.012","journal-title":"Neurobiol Aging"},{"issue":"6286","key":"2419_CR28","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352(6286):712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","journal-title":"Science"},{"issue":"6","key":"2419_CR29","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic B, Huntley MA, De Mazi\u00e8re A, Meilandt WJ, Wu T, Srinivasan K, Jiang Z, Gandham V et al (2018) Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies. Neuron 100(6):1322\u20131336. https:\/\/doi.org\/10.1016\/j.neuron.2018.10.014","journal-title":"Neuron"},{"issue":"6","key":"2419_CR30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ana.24398","volume":"77","author":"I Michailidou","year":"2015","unstructured":"Michailidou I, Willems JG, Kooi EJ, van Eden C, Gold SM, Geurts JJ, Baas F, Huitinga I et al (2015) Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. Ann Neurol 77(6):1007\u20131026. https:\/\/doi.org\/10.1002\/ana.24398","journal-title":"Ann Neurol"},{"issue":"1","key":"2419_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0611-x","volume":"13","author":"LM Watkins","year":"2016","unstructured":"Watkins LM, Neal JW, Loveless S, Michailidou I, Ramaglia V, Rees MI, Reynolds R, Robertson NP et al (2016) Complement is activated in progressive multiple sclerosis cortical grey matter lesions. J Neuroinflamm 13(1):1\u201313. https:\/\/doi.org\/10.1186\/s12974-016-0611-x","journal-title":"J Neuroinflamm"},{"issue":"3","key":"2419_CR32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","volume":"22","author":"CM Sellgren","year":"2019","unstructured":"Sellgren CM, Gracias J, Watmuff B, Biag JD, Thanos JM, Whittredge PB, Fu T, Worringer K et al (2019) Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nature Neurosci 22(3):374\u2013385. https:\/\/doi.org\/10.1038\/s41593-018-0334-7","journal-title":"Nature Neurosci"},{"issue":"1","key":"2419_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000604","volume":"18","author":"AL Comer","year":"2020","unstructured":"Comer AL, Jinadasa T, Sriram B, Phadke RA, Kretsge LN, Nguyen TPH, Antognetti G, Gilbert JP et al (2020) Increased expression of schizophrenia-associated gene C4 leads to hypoconnectivity of prefrontal cortex and reduced social interaction. PLoS Biol 18(1):e3000604. https:\/\/doi.org\/10.1371\/journal.pbio.3000604","journal-title":"PLoS Biol"},{"issue":"1","key":"2419_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ng0598-56","volume":"19","author":"M Botto","year":"1998","unstructured":"Botto M, Dell\u2019Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP et al (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genet 19(1):56\u201359. https:\/\/doi.org\/10.1038\/ng0598-56","journal-title":"Nature Genet"},{"issue":"25","key":"2419_CR35","doi-asserted-by":"publisher","first-page":"11490","DOI":"10.1073\/pnas.92.25.11490","volume":"92","author":"MR Wessels","year":"1995","unstructured":"Wessels MR, Butko P, Ma M, Warren HB, Lage AL, Carroll MC (1995) Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A 92(25):11490\u201311494. https:\/\/doi.org\/10.1073\/pnas.92.25.11490","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2419_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.molimm.2008.09.003","volume":"46","author":"MM Ruseva","year":"2009","unstructured":"Ruseva MM, Hughes TR, Donev RM, Sivasankar B, Pickering MC, Wu X, Harris CL, Morgan BP (2009) Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury. Mol Immunol 46(5):803\u2013811. https:\/\/doi.org\/10.1016\/j.molimm.2008.09.003","journal-title":"Mol Immunol"},{"issue":"5","key":"2419_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, Saido TC (2014) Single app knock-in mouse models of Alzheimer\u2019s disease. Nature Neurosci 17(5):661\u2013663. https:\/\/doi.org\/10.1038\/nn.3697","journal-title":"Nature Neurosci"},{"issue":"3","key":"2419_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP et al (2003) Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39(3):409\u2013421. https:\/\/doi.org\/10.1016\/s0896-6273(03)00434-3","journal-title":"Neuron"},{"issue":"5","key":"2419_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0161-5890(93)90111-N","volume":"30","author":"MG Wing","year":"1993","unstructured":"Wing MG, Seilly DJ, Bridgman DJ, Harrison RA (1993) Rapid isolation and biochemical characterization of rat C1 and C1q. Mol Immunol 30(5):433\u2013440. https:\/\/doi.org\/10.1016\/0161-5890(93)90111-N","journal-title":"Mol Immunol"},{"issue":"24","key":"2419_CR40","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1073\/pnas.1722613115","volume":"115","author":"BA Gy\u00f6rffy","year":"2018","unstructured":"Gy\u00f6rffy BA, Kun J, T\u00f6r\u00f6k G, Buly\u00e1ki \u00c9, Borhegyi Z, Guly\u00e1ssy P, Kis V, Szocsics P et al (2018) Local apoptotic-like mechanisms underlie complement mediated synaptic pruning. Proc Natl Acad Sci U S A 115(24):6303\u20136308. https:\/\/doi.org\/10.1073\/pnas.1722613115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2419_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0022-1759(02)00207-7","volume":"268","author":"CL Harris","year":"2002","unstructured":"Harris CL, Lublin DM, Morgan BP (2002) Efficient generation of monoclonal antibodies for specific protein domains using recombinant immunoglobulin fusion proteins: Pitfalls and solutions. J Immunol Methods 268(2):245\u2013258. https:\/\/doi.org\/10.1016\/S0022-1759(02)00207-7","journal-title":"J Immunol Methods"},{"issue":"12","key":"2419_CR42","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.imbio.2018.07.016","volume":"223","author":"WM Zelek","year":"2018","unstructured":"Zelek WM, Harris CL, Morgan BP (2018) Extracting the barbs from complement assays: Identification and optimisation of a safe substitute for traditional buffers. Immunobiol 223(12):744\u2013749. https:\/\/doi.org\/10.1016\/j.imbio.2018.07.016","journal-title":"Immunobiol"},{"issue":"4","key":"2419_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/imm.13083","volume":"157","author":"WM Zelek","year":"2019","unstructured":"Zelek WM, Taylor PR, Morgan BP (2019) Development and characterization of novel anti-C5 monoclonal antibodies capable of inhibiting complement in multiple species. Immunology 157(4):283\u2013295. https:\/\/doi.org\/10.1111\/imm.13083","journal-title":"Immunology"},{"issue":"6","key":"2419_CR44","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1128\/CDLI.9.6.1235","volume":"9","author":"GF Reed","year":"2002","unstructured":"Reed GF, Lynn F, Meade BD (2002) Use of coefficient of variation in assessing variability of quantitative assays. Clin Diag Lab Immunol 9(6):1235\u20131239. https:\/\/doi.org\/10.1128\/CDLI.9.6.1235","journal-title":"Clin Diag Lab Immunol"},{"issue":"179","key":"2419_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2015.00179","volume":"6","author":"U Andreasson","year":"2015","unstructured":"Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJ, Blennow K, Chiasserini D, Engelborghs S, Fladby T, Genc S et al (2015) A practical guide to immunoassay method validation. Front Neurol 6(179):1\u20138. https:\/\/doi.org\/10.3389\/fneur.2015.00179","journal-title":"Front Neurol"},{"issue":"3","key":"2419_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/1099800411404061","volume":"13","author":"SK Hanneman","year":"2011","unstructured":"Hanneman SK, Cox CD, Green KE, Kang DH (2011) Estimating intra- and inter-assay variability in salivary cortisol. Biol Res Nurs 13(3):243\u2013250. https:\/\/doi.org\/10.1177\/1099800411404061","journal-title":"Biol Res Nurs"},{"key":"2419_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fimmu.2019.00007","volume":"10","author":"K Sandholm","year":"2019","unstructured":"Sandholm K, Persson B, Skattum L, Eggertsen G, Nyman D, Gunnarsson I, Svenungson E, Nilsson B et al (2019) Evaluation of a novel immunoassay for quantification of C1q for clinical diagnostic use. Front Immunol 10:7. https:\/\/doi.org\/10.3389\/fimmu.2019.00007","journal-title":"Front Immunol"},{"key":"2419_CR48","doi-asserted-by":"publisher","unstructured":"Barthet G, Mulle C (2020) Presynaptic failure in Alzheimer\u2019s disease. Prog Neurobiol. Nov;194:101801. https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101801","DOI":"10.1016\/j.pneurobio.2020.101801"},{"issue":"12","key":"2419_CR49","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1002\/eji.200425616","volume":"34","author":"J Cortes-Hernandez","year":"2004","unstructured":"Cortes-Hernandez J, Fossati-Jimack L, Petry F, Loos M, Izui S, Walport MJ, Cook HT, Botto M (2004) Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice. Eur J Immunol 34(12):3713\u20133722. https:\/\/doi.org\/10.1002\/eji.200425616","journal-title":"Eur J Immunol"},{"key":"2419_CR50","doi-asserted-by":"publisher","first-page":"14453","DOI":"10.1038\/srep14453","volume":"5","author":"C Yabumoto","year":"2015","unstructured":"Yabumoto C, Akazawa H, Yamamoto R, Yano M, Kudo-Sakamoto Y, Sumida T, Kamo T, Yagi H et al (2015) Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression. Sci Rep 5:14453. https:\/\/doi.org\/10.1038\/srep14453","journal-title":"Sci Rep"},{"issue":"33","key":"2419_CR51","doi-asserted-by":"publisher","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","volume":"33","author":"AH Stephan","year":"2013","unstructured":"Stephan AH, Madison DV, Mateos JM, Fraser DA, Lovelett EA, Coutellier L, Kim L, Tsai HH et al (2013) A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci 33(33):13460\u201313474. https:\/\/doi.org\/10.1523\/JNEUROSCI.1333-13.2013","journal-title":"J Neurosci"},{"issue":"1","key":"2419_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-0814-9","volume":"14","author":"MI Fonseca","year":"2017","unstructured":"Fonseca MI, Chu SH, Hernandez MX, Fang MJ, Modarresi L, Selvan P, MacGregor GR, Tenner AJ (2017) Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain. J Neuroinflamm 14(1):1\u201315. https:\/\/doi.org\/10.1186\/s12974-017-0814-9","journal-title":"J Neuroinflamm"},{"issue":"6","key":"2419_CR53","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cell.2012.03.047","volume":"149","author":"AT Naito","year":"2012","unstructured":"Naito AT, Sumida T, Nomura S, Liu ML, Higo T, Nakagawa A, Okada K, Sakai T et al (2012) Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell 149(6):1298\u20131313. https:\/\/doi.org\/10.1016\/j.cell.2012.03.047","journal-title":"Cell"},{"issue":"3","key":"2419_CR54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/clind\/15.6.1049","volume":"35","author":"K Yonemasu","year":"1978","unstructured":"Yonemasu K, Kitajima H, Tanabe S, Ochi T, Shinkai H (1978) Effect of age on C1q and C3 levels in human serum and their presence in colostrum. Immunology 35(3):523\u2013530. https:\/\/doi.org\/10.1093\/clind\/15.6.1049","journal-title":"Immunology"},{"issue":"3","key":"2419_CR55","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1096\/fj.14-262154","volume":"29","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, Sato K, Hasegawa N, Kurihara T, Matsutani K, Sanada K, Hamaoka T, Fujita S et al (2015) Serum C1q as a novel biomarker of sarcopenia in older adults. FASEB J 29(3):1003\u20131010. https:\/\/doi.org\/10.1096\/fj.14-262154","journal-title":"FASEB J"},{"issue":"5","key":"2419_CR56","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0197-4580(94)00055-7","volume":"15","author":"MD Smyth","year":"1994","unstructured":"Smyth MD, Cribbs DH, Tenner AJ, Shankle WR, Dick M, Kesslak JP, Cotman CW (1994) Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state. Neurobiol Aging 15(5):609\u2013614. https:\/\/doi.org\/10.1016\/0197-4580(94)00055-7","journal-title":"Neurobiol Aging"},{"issue":"3","key":"2419_CR57","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/eji.201444948","volume":"45","author":"PT Pekkarinen","year":"2015","unstructured":"Pekkarinen PT, Heikkil\u00e4 N, Kisand K, Peterson P, Botto M, Daha MR, Drouet C, Isaac L et al (2015) Dysregulation of adaptive immune responses in complement C3-deficient patients. Eur J Immunol 45(3):915\u2013921. https:\/\/doi.org\/10.1002\/eji.201444948","journal-title":"Eur J Immunol"},{"issue":"6","key":"2419_CR58","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.imbio.2015.05.001","volume":"221","author":"D Scott","year":"2016","unstructured":"Scott D, Botto M (2016) The paradoxical roles of C1q and C3 in autoimmunity. Immunobiol 221(6):719\u2013725. https:\/\/doi.org\/10.1016\/j.imbio.2015.05.001","journal-title":"Immunobiol"},{"issue":"5","key":"2419_CR59","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1042\/CS20020362","volume":"104","author":"DS Cole","year":"2003","unstructured":"Cole DS, Morgan BP (2003) Beyond lysis: How complement influences cell fate. Clin Sci 104(5):455\u2013466. https:\/\/doi.org\/10.1042\/CS20020362","journal-title":"Clin Sci"},{"issue":"35","key":"2419_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-6-35","volume":"6","author":"J Reichwald","year":"2009","unstructured":"Reichwald J, Danner S, Wiederhold KH, Staufenbiel M (2009) Expression of complement system components during aging and amyloid deposition in APP transgenic mice. J Neuroinflamm 6(35):1\u201312. https:\/\/doi.org\/10.1186\/1742-2094-6-35","journal-title":"J Neuroinflamm"},{"issue":"4","key":"2419_CR61","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","volume":"182","author":"WT Chen","year":"2020","unstructured":"Chen WT, Lu A, Craessaerts K, Pavie B, Sala Frigerio C, Corthout N, Qian X, Lal\u00e1kov\u00e1 J et al (2020) Spatial transcriptomics and in situ sequencing to study Alzheimer\u2019s disease. Cell 182(4):976\u2013991. https:\/\/doi.org\/10.1016\/j.cell.2020.06.038","journal-title":"Cell"},{"issue":"1","key":"2419_CR62","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1074\/jbc.M112.400168","volume":"288","author":"ME Benoit","year":"2013","unstructured":"Benoit ME, Hernandez MX, Dinh ML, Benavente F, Vasquez O, Tenner AJ et al (2013) C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models are essential for the C1q-mediated protection against amyloid- \u03b2 neurotoxicity. J Biol Chem 288(1):654\u2013665. https:\/\/doi.org\/10.1074\/jbc.M112.400168","journal-title":"J Biol Chem"},{"issue":"1","key":"2419_CR63","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/exnr.1996.0043","volume":"138","author":"A Afagh","year":"1996","unstructured":"Afagh A, Cummings BJ, Cribbs DH, Cotman CW, Tenner AJ (1996) Localization and cell association of C1q in Alzheimer\u2019s disease brain. Exp Neurol 138(1):22\u201332. https:\/\/doi.org\/10.1006\/exnr.1996.0043","journal-title":"Exp Neurol"},{"issue":"6","key":"2419_CR64","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/BF00192116","volume":"426","author":"R Veerhuis","year":"1995","unstructured":"Veerhuis R, van der Valk P, Janssen I, Zhan SS, Van Nostrand WE, Eikelenboom P (1995) Complement activation in amyloid plaques in Alzheimer\u2019s disease brains does not proceed further than C3. Virch Archiv 426(6):603\u2013610. https:\/\/doi.org\/10.1007\/BF00192116","journal-title":"Virch Archiv"},{"key":"2419_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.molimm.2017.05.025","volume":"89","author":"NM Thielens","year":"2017","unstructured":"Thielens NM, Tedesco F, Bohlson SS, Gaboriaud C, Tenner AJ (2017) C1q: A fresh look upon an old molecule. Mol Immunol 89:73\u201383. https:\/\/doi.org\/10.1016\/j.molimm.2017.05.025","journal-title":"Mol Immunol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02419-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02419-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02419-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T14:18:30Z","timestamp":1633357110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02419-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2419"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02419-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"5 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No human subjects were involved in this research so informed consent is not relevant. Animals use was under the auspices of UK Home Office Licence numbers PF4167C0A and P8159A562.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"No human subjects were involved in this research, so consent to participate is not relevant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have approved this manuscript and consented to its submission for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}